Literature DB >> 1738940

Intragraft cytokine profile during human liver allograft rejection.

O M Martinez1, S M Krams, M Sterneck, J C Villanueva, D A Falco, L D Ferrell, J Lake, J P Roberts, N L Ascher.   

Abstract

Forty-three human liver allograft biopsies and normal liver were directly analyzed for inflammatory and immunoregulatory cytokine gene expression by polymerase chain reaction (PCR). IL-5 gene expression was predominantly present in biopsies from liver allografts with histopathological evidence of acute rejection. IL-2 gene expression was rarely observed in rejecting allografts or allografts without evidence of rejection. In contrast, IL-4 message was readily detectable in the majority of liver allografts regardless of clinical status. The inflammatory mediators IL-1 beta, TNF-alpha, and IL-6 were detected with similar frequency in rejecting allografts and allografts without evidence of rejection. These findings suggest that inflammatory and immunoregulatory cytokines are produced within the allograft. Moreover, IL-5 may play a role in the local mechanisms of liver allograft rejection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1738940     DOI: 10.1097/00007890-199202010-00035

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

1.  Assessment of immunologic status of liver transplant recipients by peripheral blood mononuclear cells in response to stimulation by donor alloantigen.

Authors:  Y Chen; G J McKenna; E M Yoshida; A K Buczkowski; C H Scudamore; S R Erb; U P Steinbrecher; S W Chung
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

Review 2.  Renal transplant fine needle aspiration and cytokine gene expression.

Authors:  C C Nast
Journal:  Pediatr Nephrol       Date:  1995       Impact factor: 3.714

Review 3.  Scarless wound healing: implications for the aesthetic surgeon.

Authors:  J Chang; J W Siebert; S A Schendel; B H Press; M T Longaker
Journal:  Aesthetic Plast Surg       Date:  1995 May-Jun       Impact factor: 2.326

4.  TNF-alpha dependent production of inducible nitric oxide is involved in PGE(1) protection against acute liver injury.

Authors:  J Muntané; F J Rodríguez; O Segado; A Quintero; J M Lozano; E Siendones; C A Pedraza; M Delgado; F O'Valle; R García; J L Montero; M De La Mata; G Miño
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

5.  Altered patterns of migration of cytokine-producing T lymphocytes in skin-grafted naive or immune mice following in vivo administration of anti-VCAM-1 or -ICAM-1.

Authors:  R M Gorczynski; S Chung; Y Hoang; B Sullivan; Z Chen
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

6.  Cytokine mRNA expression in endomyocardial biopsies during acute rejection from human heart transplants.

Authors:  C C Baan; N E van Emmerik; A H Balk; W G Quint; B Mochtar; N H Jutte; H G Niesters; W Weimar
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

7.  Determination of the presence of interleukin-6 in bile after orthotopic liver transplantation. Its role in the diagnosis of acute rejection.

Authors:  K Umeshita; M Monden; T Tono; Y Hasuike; T Kanai; M Gotoh; T Mori; A Shaked; R W Busuttil
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969

8.  Expression of cytokine genes in human cardiac allografts: correlation of IL-6 and transforming growth factor-beta (TGF-beta) with histological rejection.

Authors:  X M Zhao; W H Frist; T K Yeoh; G G Miller
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

9.  Characterization of mixed syngeneic-allogeneic and syngeneic-xenogeneic islet-graft rejections in mice. Evidence of functional impairment of the remaining syngeneic islets in xenograft rejections.

Authors:  O Korsgren; L Jansson
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

10.  Cytokines in clinical and experimental transplantation.

Authors:  A C Vossen; H F Savelkoul
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.